114 related articles for article (PubMed ID: 6823776)
1. The possible prognostic value of serum prolactin increment during pregnancy in hyperprolactinaemic patients.
Andersen AN; Starup J; Tabor A; Jensen HK; Westergaard JG
Acta Endocrinol (Copenh); 1983 Jan; 102(1):1-5. PubMed ID: 6823776
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic value of pharmacodynamic tests in the hyperprolactinaemic syndrome.
Ayalon D; Persitz E; Ravid R; Jedwab G; Avidan S; Cordova T; Harell A
Clin Endocrinol (Oxf); 1979; 11(2):201-15. PubMed ID: 114343
[TBL] [Abstract][Full Text] [Related]
3. Hyperprolactinaemic amenorrhoea in Hong Kong.
Tang LC; Sung ML; Ma HK
Aust N Z J Obstet Gynaecol; 1983 Aug; 23(3):165-9. PubMed ID: 6580885
[TBL] [Abstract][Full Text] [Related]
4. Decrease in serum prolactin during bromocriptine-induced pregnancy and subsequent restoration of reproductive function in some hyperprolactinemic women.
Seki K; Kato K
Endocrinol Jpn; 1987 Oct; 34(5):701-7. PubMed ID: 3436300
[TBL] [Abstract][Full Text] [Related]
5. Prolactin levels in pregnancy: comparison of normal subjects with patients having micro- or macroadenomas after early bromocriptine withdrawal.
Woodhouse NJ; Niles N; McDonald D; McCorkell S
Horm Res; 1985; 21(1):1-9. PubMed ID: 3972334
[TBL] [Abstract][Full Text] [Related]
6. Relationship between maternal prolactin levels during pregnancy and lactation in women with pituitary adenoma.
Narita O; Kimura T; Suganuma N; Osawa M; Mizutani S; Masahashi T; Asai M; Tomoda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):758-62. PubMed ID: 3998551
[TBL] [Abstract][Full Text] [Related]
7. Normal and abnormal prolactin levels during human pregnancy. Lack of influence on fetoplacental endocrine function.
Andersen AN; Pedersen H; Westergaard JG; Schiøler V; Arends J
Acta Obstet Gynecol Scand; 1984; 63(2):145-8. PubMed ID: 6730928
[TBL] [Abstract][Full Text] [Related]
8. Regression of pituitary microadenoma during and following bromocriptine therapy: persistent defect in prolactin regulation before and throughout pregnancy.
Yuen BH; Cannon W; Sy L; Booth J; Burch P
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 1):634-9. PubMed ID: 7065035
[TBL] [Abstract][Full Text] [Related]
9. The safety of bromocriptine in hyperprolactinaemic female infertility: a literature review.
Weil C
Curr Med Res Opin; 1986; 10(3):172-95. PubMed ID: 3525009
[TBL] [Abstract][Full Text] [Related]
10. Influence of pregnancies on prolactinomas.
Rjosk HK; Fahlbusch R; von Werder K
Acta Endocrinol (Copenh); 1982 Jul; 100(3):337-46. PubMed ID: 7113602
[TBL] [Abstract][Full Text] [Related]
11. Effect of bromocriptine and metergoline in the treatment of hyperprolactinaemic states.
Ambrosi B; Travaglini P; Moriondo P; Nissim M; Nava C; Bochicchio D; Faglia G
Acta Endocrinol (Copenh); 1982 May; 100(1):10-7. PubMed ID: 6810607
[TBL] [Abstract][Full Text] [Related]
12. [Pregnancy and hyperprolactinemia].
Hoffmann G; Ackermann RH; Happ J; Hey O; Pollow K
Exp Clin Endocrinol; 1983 May; 81(3):336-46. PubMed ID: 6684065
[TBL] [Abstract][Full Text] [Related]
13. Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea.
Bergh T; Nillius SJ; Wide L
Acta Endocrinol (Copenh); 1978 Jul; 88(3):435-51. PubMed ID: 354299
[TBL] [Abstract][Full Text] [Related]
14. Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia.
Bergh T; Nillius SJ; Lundberg PO; Moström U; Enoksson P; Ohman L; Wide L
Ups J Med Sci; 1982; 87(3):259-67. PubMed ID: 7157557
[TBL] [Abstract][Full Text] [Related]
15. Return of menstruation and normalization of prolactin in hyperprolactinemic women with bromocriptine-induced pregnancy.
Rasmussen C; Bergh T; Nillius SJ; Wide L
Fertil Steril; 1985 Jul; 44(1):31-4. PubMed ID: 4007192
[TBL] [Abstract][Full Text] [Related]
16. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
Nillius SJ
Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
[TBL] [Abstract][Full Text] [Related]
17. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
18. [Acute pituitary failure as the presentation of a prolactin cell adenoma during a pregnancy made possible by bromocriptine (author's transl)].
Linquette M; Buvat J; Gauthier A; Gasnault JP; Pagniez I; Decoulx M; Laine E
Nouv Presse Med; 1977 Nov; 6(38):3525-L, 3531. PubMed ID: 600724
[TBL] [Abstract][Full Text] [Related]
19. Outcome of treatment with bromocriptine in patients with hyperprolactinaemia.
al-Suleiman SA; Najashi S; Rahman J; Rahman MS
Aust N Z J Obstet Gynaecol; 1989 May; 29(2):176-9. PubMed ID: 2803131
[TBL] [Abstract][Full Text] [Related]
20. Effect of tamoxifen administration on prolactin release by invasive prolactin-secreting pituitary adenomas.
Lamberts SW; Verleun T; Oosterom R
Neuroendocrinology; 1982; 34(5):339-42. PubMed ID: 7078703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
